Exploring the chemical and pharmacological variability of Lepidium meyenii: a comprehensive review of the effects of maca
- PMID: 38440178
- PMCID: PMC10910417
- DOI: 10.3389/fphar.2024.1360422
Exploring the chemical and pharmacological variability of Lepidium meyenii: a comprehensive review of the effects of maca
Abstract
Maca (Lepidium meyenii), a biennial herbaceous plant indigenous to the Andes Mountains, has a rich history of traditional use for its purported health benefits. Maca's chemical composition varies due to ecotypes, growth conditions, and post-harvest processing, contributing to its intricate phytochemical profile, including, macamides, macaenes, and glucosinolates, among other components. This review provides an in-depth revision and analysis of Maca's diverse bioactive metabolites, focusing on the pharmacological properties registered in pre-clinical and clinical studies. Maca is generally safe, with rare adverse effects, supported by preclinical studies revealing low toxicity and good human tolerance. Preclinical investigations highlight the benefits attributed to Maca compounds, including neuroprotection, anti-inflammatory properties, immunoregulation, and antioxidant effects. Maca has also shown potential for enhancing fertility, combating fatigue, and exhibiting potential antitumor properties. Maca's versatility extends to metabolic regulation, gastrointestinal health, cardio protection, antihypertensive activity, photoprotection, muscle growth, hepatoprotection, proangiogenic effects, antithrombotic properties, and antiallergic activity. Clinical studies, primarily focused on sexual health, indicate improved sexual desire, erectile function, and subjective wellbeing in men. Maca also shows promise in alleviating menopausal symptoms in women and enhancing physical performance. Further research is essential to uncover the mechanisms and clinical applications of Maca's unique bioactive metabolites, solidifying its place as a subject of growing scientific interest.
Keywords: Lepidium meyenii; clinical studies; glucosilonates; maca; macaenes; macamides; pharmacology; preclinical.
Copyright © 2024 Ulloa del Carpio, Alvarado-Corella, Quiñones-Laveriano, Araya-Sibaja, Vega-Baudrit, Monagas-Juan, Navarro-Hoyos and Villar-López.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Alvarado A. T., Navarro C., Pineda M., Villanueva L., Muñoz A. M., Bendezú M. R., et al. (2022). Activity of Lepidium meyenii Walp (purple maca) in immunosuppressed Oryctolagus cuniculus (albino rabbits). Pharmacia 69, 501–507. 10.3897/pharmacia.69.e80033 - DOI
-
- Antoine E., Chirila S., Teodorescu C. (2019). A patented blend consisting of a combination of vitex agnus-castus extract, lepidium meyenii (maca) extract and active folate, a nutritional supplement for improving fertility in women. Maedica 14, 274–279. 10.26574/maedica.2019.14.3.274 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
